ChemoTox Report - Breast Cancer

ChemoTox Report™ – Breast Cancer

Genetic Screening to Help Identify Chemotherapy Toxicity Risk

Chemotherapy can be highly effective in treating breast cancer, but each person's body processes medications differently. Genetic differences can affect the enzymes and pathways involved in breaking down certain chemotherapy medications, which may influence medication exposure and the risk of serious side effects.

ChemoTox Report™ – Breast Cancer is a pharmacogenomic screening designed to identify genetic factors that may affect how your body processes selected breast cancer medications. The results provide your oncology team with additional information that may help support safer, more personalized treatment decisions.

Testing can be completed before chemotherapy begins or during treatment. Understanding your genetic profile may help your healthcare provider identify potential medication toxicity risks and determine whether additional precautions, monitoring, dose considerations, or treatment adjustments may be appropriate.

What's Included

Your ChemoTox Report™ – Breast Cancer includes:

• Multi-gene pharmacogenomic analysis focused on chemotherapy metabolism and toxicity risk
• Analysis of clinically relevant genetic variants associated with selected breast cancer medications
• Evaluation of genetic factors that may influence medication metabolism, exposure, and toxicity
• Professional clinical report designed for review by your oncologist or healthcare provider
• Medical review by a clinical MD/PhD
• Personalized genetic information that may help your healthcare team make more informed treatment decisions

Supporting Safer, More Personalized Cancer Treatment

Your oncologist selects chemotherapy based on the characteristics of your cancer and your individual treatment needs. ChemoTox Report™ provides another layer of information by examining genetic factors that may influence how your body processes certain chemotherapy medications.

The goal is to give you and your oncology team additional information before and during treatment so that potential genetic risk factors can be considered when making treatment decisions.

Laboratory & Medical Review

ChemoTox Report™ is medically reviewed by a clinical MD/PhD. Genetic testing is processed through PGX Lab Solutions, a College of American Pathologists (CAP) accredited laboratory with ISO 9001 and ISO 27001 certifications.

Please note: ChemoTox Report™ does not diagnose cancer, determine whether chemotherapy is required, or replace the clinical judgment of your oncologist or healthcare provider. Treatment and dosing decisions should always be made by your healthcare team.

Sample Report

View Sample Report (PDF)

View Sample Online Report using

Email: guest@personalizedprescribing.com

Password: Guest2019!

Shipping

Once you purchase your test, we will mail you a DNA sample collection kit containing everything you need to complete and return your sample.

Your sample collection package includes:

• A DNA cheek swab collection kit
• Step-by-step sample collection instructions
• A prepaid return envelope for mailing your sample to our laboratory

Shipping is included in the purchase price—there are no additional shipping charges.

To ensure prompt delivery, please provide your complete and accurate mailing address when placing your order.

Estimated Delivery Times

• Ontario: 3–5 business days
• Major cities outside Ontario: 5–7 business days
• Rural or remote locations: Delivery may take longer depending on your location.

All sample collection kits are shipped via Canada Post.

Please note that delivery times are estimates only and may be affected by factors beyond our control, including severe weather, postal service delays, labour disruptions, holidays, or address inaccuracies. While we strive to ensure timely delivery, Personalized Prescribing Inc. (PPI) cannot guarantee delivery within the estimated timeframe under exceptional circumstances.